The prognostic impact of high Nijmegen breakage syndrome (NBS1) gene expression in ERG‐negative prostate cancers lacking PTEN deletion is driven by KPNA2 expression
暂无分享,去创建一个
G. Sauter | T. Schlomm | S. Steurer | R. Simon | W. Wilczak | S. Minner | M. Tsourlakis | M. Graefen | H. Huland | J. Izbicki | A. Quaas | K. Grupp | C. Koop | Meike Adam | Rebecca Boumesli
[1] J. Korbel,et al. Genomic deletion of MAP3K7 at 6q12-22 is associated with early PSA recurrence in prostate cancer and absence of TMPRSS2:ERG fusions , 2013, Modern Pathology.
[2] G. Sauter,et al. CHD1 is a 5q21 tumor suppressor required for ERG rearrangement in prostate cancer. , 2013, Cancer research.
[3] V. Beneš,et al. Integrative genomic analyses reveal an androgen-driven somatic alteration landscape in early-onset prostate cancer. , 2013, Cancer cell.
[4] K. Khanna,et al. Inactivation of ATM/ATR DNA Damage Checkpoint Promotes Androgen Induced Chromosomal Instability in Prostate Epithelial Cells , 2012, PloS one.
[5] A Jakubowska,et al. An inherited NBN mutation is associated with poor prognosis prostate cancer , 2012, British Journal of Cancer.
[6] J. Carpten,et al. Identification of a novel NBN truncating mutation in a family with hereditary prostate cancer , 2012, Familial Cancer.
[7] C. Plass,et al. Genomic deletion of PTEN is associated with tumor progression and early PSA recurrence in ERG fusion-positive and fusion-negative prostate cancer. , 2012, The American journal of pathology.
[8] R. Medeiros,et al. DNA repair system and prostate cancer progression: the role of NBS1 polymorphism (rs1805794). , 2012, DNA and cell biology.
[9] H. Schlüter,et al. ERG Status Is Unrelated to PSA Recurrence in Radically Operated Prostate Cancer in the Absence of Antihormonal Therapy , 2011, Clinical Cancer Research.
[10] Wei Yan,et al. Mechanistic rationale for inhibition of poly(ADP-ribose) polymerase in ETS gene fusion-positive prostate cancer. , 2011, Cancer cell.
[11] G. Kristiansen,et al. KPNA2 Expression Is an Independent Adverse Predictor of Biochemical Recurrence after Radical Prostatectomy , 2011, Clinical Cancer Research.
[12] Eric S. Lander,et al. The genomic complexity of primary human prostate cancer , 2010, Nature.
[13] M. Weitzman,et al. The MRN complex in double‐strand break repair and telomere maintenance , 2010, FEBS letters.
[14] C. Sander,et al. Integrative genomic profiling of human prostate cancer. , 2010, Cancer cell.
[15] Martin J. Aryee,et al. Androgen-induced TOP2B mediated double strand breaks and prostate cancer gene rearrangements , 2010, Nature Genetics.
[16] A. Haese*,et al. Clinical significance of p53 alterations in surgically treated prostate cancers , 2008, Modern Pathology.
[17] J. Brooks,et al. Genomic profiling reveals alternative genetic pathways of prostate tumorigenesis. , 2007, Cancer research.
[18] P. Pandolfi,et al. Essential Role for Nuclear PTEN in Maintaining Chromosomal Integrity , 2007, Cell.
[19] J. Cerhan,et al. Role of the Nijmegen Breakage Syndrome 1 Gene in Familial and Sporadic Prostate Cancer , 2006, Cancer Epidemiology Biomarkers & Prevention.
[20] J. Tchinda,et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. , 2006, Science.
[21] H. Tauchi,et al. Nijmegen breakage syndrome and functions of the responsible protein, NBS1. , 2006, Genome dynamics.
[22] Kou-Juey Wu,et al. Importin KPNA2 Is Required for Proper Nuclear Localization and Multiple Functions of NBS1* , 2005, Journal of Biological Chemistry.
[23] R. Parsons,et al. PTEN Loss Inhibits CHK1 to Cause Double Stranded-DNA Breaks in Cells , 2005, Cell cycle.
[24] T. Pandita,et al. Lack of PTEN sequesters CHK1 and initiates genetic instability. , 2005, Cancer cell.
[25] A. Jakubowska,et al. NBS1 Is a Prostate Cancer Susceptibility Gene , 2004, Cancer Research.
[26] Johnson M Liu,et al. Chromosomal breakage syndromes and the BRCA1 genome surveillance complex. , 2001, Trends in molecular medicine.
[27] J. Carpten,et al. A genetic epidemiological study of hereditary prostate cancer (HPC) in Finland: frequent HPCX linkage in families with late-onset disease. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[28] Matthias Platzer,et al. Nibrin, a Novel DNA Double-Strand Break Repair Protein, Is Mutated in Nijmegen Breakage Syndrome , 1998, Cell.
[29] John R Yates,et al. The hMre11/hRad50 Protein Complex and Nijmegen Breakage Syndrome: Linkage of Double-Strand Break Repair to the Cellular DNA Damage Response , 1998, Cell.
[30] H. Moch,et al. Ki67 LABELLING INDEX: AN INDEPENDENT PREDICTOR OF PROGRESSION IN PROSTATE CANCER TREATED BY RADICAL PROSTATECTOMY , 1996, The Journal of pathology.
[31] Robin J. Leach,et al. Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer , 1993, Cell.
[32] K. Kinzler,et al. Clues to the pathogenesis of familial colorectal cancer. , 1993, Science.
[33] J. Weber,et al. Genetic mapping of a locus predisposing to human colorectal cancer. , 1993, Science.
[34] H. Lynch,et al. Hereditary nonpolyposis colorectal cancer (Lynch syndromes I and II): a common genotype linked to oncogenes? , 1985, Medical hypotheses.
[35] R. Taalman,et al. A NEW CHROMOSOMAL INSTABILITY DISORDER: THE NIJMEGEN BREAKAGE SYNDROME , 1981, Acta paediatrica Scandinavica.
[36] G. Sauter,et al. High nuclear karyopherin α 2 expression is a strong and independent predictor of biochemical recurrence in prostate cancer patients treated by radical prostatectomy , 2014, Modern Pathology.
[37] J. Gardovskis,et al. Epidemiologic, clinical, and molecular characteristics of hereditary prostate cancer in Latvia. , 2011, Medicina.
[38] Michael S. Becker,et al. The role of mechanistic factors in promoting chromosomal translocations found in lymphoid and other cancers. , 2010, Advances in immunology.
[39] Ronald Simon,et al. Immunohistochemical analysis of tissue microarrays. , 2010, Methods in molecular biology.
[40] Ronald Simon,et al. Recipient block TMA technique. , 2010, Methods in molecular biology.
[41] Ronald Simon,et al. Tissue Microarrays , 2010, Methods in Molecular Biology.